SGLT2 Inhibitors as the Backbone of Therapy for Cardiovascular and Renal Protection

被引：0
|
作者：
Felice Gragnano
Fabrizia Terracciano
Paolo Calabrò
机构：
[1] University of Campania “Luigi Vanvitelli”,Department of Translational Medical Sciences
[2] A.O.R.N. “Sant’Anna e San Sebastiano”,Division of Clinical Cardiology
来源：
Journal of Cardiovascular Translational Research | 2024年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：227 / 229
页数：2
相关论文
共 50 条
  • [1] SGLT2 Inhibitors as the Backbone of Therapy for Cardiovascular and Renal Protection
    Gragnano, Felice
    Terracciano, Fabrizia
    Calabro, Paolo
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2024, 17 (01) : 227 - 229
  • [2] SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection
    Bell, Robert M.
    Yellon, Derek M.
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (06): : 435 - 437
  • [3] Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
    Davide Margonato
    Giuseppe Galati
    Simone Mazzetti
    Rosa Cannistraci
    Gianluca Perseghin
    Alberto Margonato
    Andrea Mortara
    Heart Failure Reviews, 2021, 26 : 337 - 345
  • [4] Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
    Margonato, Davide
    Galati, Giuseppe
    Mazzetti, Simone
    Cannistraci, Rosa
    Perseghin, Gianluca
    Margonato, Alberto
    Mortara, Andrea
    HEART FAILURE REVIEWS, 2021, 26 (02) : 337 - 345
  • [5] SGLT2 inhibitors: providing cardiovascular protection in type 2 diabetes?
    Wilding, John
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (05): : 379 - 381
  • [6] Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review
    Rabizadeh, Soghra
    Nakhjavani, Manouchehr
    Esteghamati, Alireza
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2019, 17 (02)
  • [7] The effect of SGLT2 inhibitors on cardiovascular events and renal function
    Imprialos, Konstantinos P.
    Stavropoulos, Konstantinos
    Doumas, Michael
    Karagiannis, Asterios
    Athyros, Vasilios G.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (11) : 1251 - 1261
  • [8] Cardiovascular safety of SGLT2 inhibitors
    Gumprecht, Janusz
    CLINICAL DIABETOLOGY, 2016, 5 (02): : 62 - 65
  • [9] Cardiovascular benefit of SGLT2 inhibitors
    Mohebi, Reza
    Januzzi, James L.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2022, 59 (03) : 142 - 155
  • [10] SGLT2 inhibitors in cardiovascular medicine
    Varzideh, Fahimeh
    Kansakar, Urna
    Santulli, Gaetano
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (04) : E67 - E68
12345